Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Diego, California 92161


Purpose:

This study is designed to assess the potential mechanism of action by which WelChol® (colesevelam) may improve blood glucose control in patients with type 2 diabetes


Criteria:

Inclusion Criteria: - Patients between the ages of 18 - 75, inclusive - Diagnosed with type 2 diabetes - Hemoglobin A1c value greater than or equal to 8.0% - Antidiabetic treatments may include sulfonylurea agents (non-sulfonylurea agents must be withdrawn) - Overweight, obese (body mass index 25-45 kg/m2) Exclusion Criteria: - Change of dose of lipid or blood pressure lowering therapy within past three months - Previous treatment with colesevelam for hyperlipidemia - Serum triglyceride greater than 500 mg/dL - Serum low density lipoprotein-cholesterol less than 60 mg/dL


NCT ID:

NCT00147745


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

San Diego, California 92161
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.